|
INN ▲
|
ATC Code ▲
|
Country ▲
|
Classification ▲
|
Last update ▲
|
MA Number ▲
|
Registration date ▲
|
Status ▲
|
|
ROZANOLIXIZUMAB |
L04AG16 |
IT
|
I
|
13-05-2024 |
EMEA/H/C/005824 |
05-01-2024 |
VALID
|
|
RUXOLITINIB |
D11AH09 |
IT
|
I
|
18-08-2023 |
EMEA/H/C/005843 |
19-04-2023 |
VALID
|
|
EFGARTIGIMOD ALFA |
L04AA58 |
IT
|
I
|
18-11-2022 |
EMEA/H/C/005849 |
10-08-2022 |
VALID
|
|
FEZOLINETANT |
G02CX06 |
IT
|
I
|
13-05-2024 |
EMEA/H/C/005851 |
07-12-2023 |
VALID
|
|
VUTRISIRAN |
N07XX18 |
IT
|
I
|
18-11-2022 |
EMEA/H/C/005852 |
15-09-2022 |
VALID
|
|
REGDANVIMAB |
J06BD06 |
IT
|
I
|
28-04-2022 |
EMEA/H/C/005854 |
12-11-2021 |
VALID
|
|
MARALIXIBAT CHLORIDE |
A05AX04 |
IT
|
I
|
18-08-2023 |
EMEA/H/C/005857 |
09-12-2022 |
VALID
|
|
TALQUETAMAB |
L01FX29 |
IT
|
I
|
14-11-2023 |
EMEA/H/C/005864 |
21-08-2023 |
VALID
|
|
ZOLBETUXIMAB |
L01FX31 |
IT
|
POM
|
01-08-2025 |
EMEA/H/C/005868 |
19-09-2024 |
VALID
|
|
ATOGEPANT |
N02CD07 |
IT
|
I
|
14-11-2023 |
EMEA/H/C/005871 |
11-08-2023 |
VALID
|
|
SPESOLIMAB |
L04AC22 |
IT
|
I
|
18-08-2023 |
EMEA/H/C/005874 |
09-12-2022 |
VALID
|
|
LEBRIKIZUMAB |
D11AH10 |
IT
|
I
|
13-05-2024 |
EMEA/H/C/005894 |
16-11-2023 |
VALID
|
|
REZAFUNGIN |
J02AX08 |
IT
|
I
|
13-05-2024 |
EMEA/H/C/005900 |
22-12-2023 |
VALID
|
|
ELRANATAMAB |
L01FX32 |
IT
|
I
|
13-05-2024 |
EMEA/H/C/005908 |
07-12-2023 |
VALID
|
|
QUIZARTINIB |
L01EX11 |
IT
|
I
|
13-05-2024 |
EMEA/H/C/005910 |
06-11-2023 |
VALID
|
|
UBLITUXIMAB |
L04AG14 |
IT
|
I
|
14-11-2023 |
EMEA/H/C/005914 |
31-05-2023 |
VALID
|
|
TISLELIZUMAB |
L01FF09 |
IT
|
I
|
14-11-2023 |
EMEA/H/C/005919 |
15-09-2023 |
VALID
|
|
PALOPEGTERIPARATIDE |
H05AA05 |
IT
|
I
|
13-05-2024 |
EMEA/H/C/005934 |
17-11-2023 |
VALID
|
|
IVOSIDENIB |
L01XM02 |
IT
|
I
|
14-11-2023 |
EMEA/H/C/005936 |
04-05-2023 |
VALID
|
|
VIBEGRON |
G04BD15 |
IT
|
POM
|
01-08-2025 |
EMEA/H/C/005957 |
27-06-2024 |
VALID
|
|
EFANESOCTOCOG ALFA |
B02BD02 |
IT
|
POM
|
01-08-2025 |
EMEA/H/C/005968 |
17-06-2024 |
VALID
|
|
NIRMATRELVIR AND RITONAVIR |
J05AE30 |
IT
|
I
|
18-08-2023 |
EMEA/H/C/005973 |
28-01-2022 |
VALID
|
|
INSULIN ICODEC |
A10AE07 |
IT
|
POM
|
01-08-2025 |
EMEA/H/C/005978 |
17-05-2024 |
VALID
|
|
FRUQUINTINIB |
L01EK04 |
IT
|
POM
|
01-08-2025 |
EMEA/H/C/005979 |
20-06-2024 |
VALID
|
|
ETRASIMOD |
L04AE05 |
IT
|
I
|
13-05-2024 |
EMEA/H/C/006007 |
16-02-2024 |
VALID
|
|
ADAGRASIB |
L01XX77 |
IT
|
I
|
13-05-2024 |
EMEA/H/C/006013 |
05-01-2024 |
VALID
|
|
CAPIVASERTIB |
L01EX27 |
IT
|
POM
|
01-08-2025 |
EMEA/H/C/006017 |
17-06-2024 |
VALID
|
|
RITLECITINIB |
L04AF08 |
IT
|
I
|
14-11-2023 |
EMEA/H/C/006025 |
15-09-2023 |
VALID
|
|
RESPIRATORY SYNCYTIAL VIRUS VACCINES |
J07BX05 |
IT
|
I
|
14-11-2023 |
EMEA/H/C/006027 |
23-08-2023 |
VALID
|
|
DOPAMINE HYDROCHLORIDE |
C01CA04 |
IT
|
POM
|
01-08-2025 |
EMEA/H/C/006044 |
27-05-2024 |
VALID
|
|
ERDAFITINIB |
L01EN01 |
IT
|
POM
|
01-08-2025 |
EMEA/H/C/006050 |
22-08-2024 |
VALID
|
|
INFLUENZA VACCINE (SURFACE ANTIGEN, INACTIVATED, PREPARED IN CELL CULTURES) |
J07BB02 |
IT
|
POM
|
01-08-2025 |
EMEA/H/C/006051 |
19-04-2024 |
VALID
|
|
CROVALIMAB |
L04AJ07 |
IT
|
POM
|
01-08-2025 |
EMEA/H/C/006061 |
22-08-2024 |
VALID
|
|
FLORTAUCIPIR (18F) |
V09AX07 |
IT
|
POM
|
01-08-2025 |
EMEA/H/C/006064 |
22-08-2024 |
VALID
|
|
DELGOCITINIB |
D11AH11 |
IT
|
POM
|
01-08-2025 |
EMEA/H/C/006109 |
19-09-2024 |
VALID
|
|
TORIPALIMAB |
L01FF13 |
IT
|
POM
|
01-08-2025 |
EMEA/H/C/006120 |
19-09-2024 |
VALID
|
|
GADOPICLENOL |
V08CA12 |
IT
|
I
|
13-05-2024 |
EMEA/H/C/006172 |
07-12-2023 |
VALID
|
|
RETIFANLIMAB |
L01FF10 |
IT
|
POM
|
01-08-2025 |
EMEA/H/C/006194 |
19-04-2024 |
VALID
|
|
DASIGLUCAGON |
H04AA02 |
IT
|
POM
|
01-08-2025 |
EMEA/H/C/006214 |
24-07-2024 |
VALID
|
|
ELAFIBRANOR |
A05AX06 |
IT
|
POM
|
01-08-2025 |
EMEA/H/C/006231 |
19-09-2024 |
VALID
|
|
SINGLE-STRANDED 5' CAPPED MRNA ENCODING RESPIRATORY SYNCYTIAL VIRUS GLYCOPROTEIN F STABILIZED |
J07BX05 |
IT
|
POM
|
01-08-2025 |
EMEA/H/C/006278 |
22-08-2024 |
VALID
|
|
INFLUENZA VACCINE (LIVE ATTENUATED, NASAL) |
J07BB03 |
IT
|
POM
|
01-08-2025 |
EMEA/H/C/006514 |
03-06-2024 |
VALID
|
|
SAMARIUM (153SM) LEXIDRONAM |
V10BX02 |
IT
|
I
|
01-06-2021 |
EMEA/H/C/150 |
05-02-1998 |
VALID
|
|
SOMATROPIN |
H01AC01 |
IT
|
II
|
03-02-2021 |
IT/H/0025/006/ |
07-11-2014 |
VALID
|
|
BECLOMETASONE |
A07EA07 |
IT
|
II
|
|
IT/H/0100/001/II/004 |
23-07-2008 |
VALID
|
|
BENZYDAMINE |
A01AD02 |
IT
|
Not subject to prescription
|
|
IT/H/0103/001/V001/ |
09-07-2002 |
VALID
|
|
MANIDIPINE |
C08CA11 |
IT
|
II
|
|
IT/H/0109/001/E001/ |
11-03-2003 |
VALID
|
|
NAPROXEN |
M02AA12 |
IT
|
II + Exemption
|
|
IT/H/0110/002/DC |
30-12-2009 |
VALID
|
|
COMBINATIONS |
A11CC20 |
IT
|
Currently not available
|
|
IT/H/0112/001/ / |
19-03-2002 |
VALID
|
|
CALCIUM, COMBINATIONS WITH VITAMIN D AND/OR OTHER DRUGS |
A12AX |
IT
|
II
|
18-08-2017 |
IT/H/0112/001/II/023 |
|
VALID
|
